Treatment of melasma using a novel 1,927-nm fractional thulium fiber laser: a pilot study.

Abstract

The 1,927-nm fractional thulium fiber laser is a safe, effective treatment for melasma.

Full Text

DOI - Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] (DOI)
Swets Information Services - full-text online
OhioLINK Electronic Journal Center - full-text online
EBSCO - full-text online
Blackwell Publishing - full-text online

Subjects

Similar articles

Split-Face Study Using a 1,927-nm Thulium Fiber Fractional Laser to Treat Photoaging and Melasma in Asian Skin. (2013-03-06)
Treatment of melasma with the 1,927-nm fractional thulium fiber laser: A retrospective analysis of 20 cases with long-term follow-up. (2012-12-19)
A retrospective study of the management of Chinese melasma patients using a 1927 nm fractional thulium fiber laser. (2013-02-05)
Adverse Events of Non-Ablative Fractional Laser Photothermolysis: A Retrospective Study of 856 Treatments in 362 Patients. (2013-05-03)
1,927-nm fractional thulium fiber laser for the treatment of nonfacial photodamage: a pilot study. (2011-03-17)
The efficacy in melasma treatment using a 1410 nm fractional photothermolysis laser. (2013-01-24)
Treatment of macular seborrheic keratoses using a novel 1927-nm fractional thulium fiber laser. (2012-07-04)
Histologic and ultrastructural analysis of melasma after fractional resurfacing. (2008-03-04)
High average power picosecond pulse generation from a thulium-doped all-fiber MOPA system. (2012-10-05)

Authors

Publication date

2012-02-07

Journal

Dermatologic surgery
Dermatol Surg (1524-4725)

Journal topics

Language

Eng.

Copyright

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]

Department of Dermatology, University of Texas at Houston, Houston, Texas, USA. kristelpolder [at] hotmail.com

Release reference

Dermatol Surg. 2012 Feb;38(2):199-206

Related books

Español | English

© Galenicom 1999-2013